Cargando…

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)

BACKGROUND: Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of anti-drug antibodies (ADAbs) in children is scarce. We ai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassar-Sheikh Rashid, A., Schonenberg-Meinema, D., Bergkamp, S. C., Bakhlakh, S., de Vries, A., Rispens, T., Kuijpers, T. W., Wolbink, G., van den Berg, J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082819/ https://www.ncbi.nlm.nih.gov/pubmed/33926495 http://dx.doi.org/10.1186/s12969-021-00545-x

Ejemplares similares

Experiences, perspectives and expectations of adolescents with juvenile idiopathic arthritis regarding future work participation; a qualitative study
por: van Gulik, E. Charlotte, et al.
Publicado: (2020)

Correlations between capillary density and degree of skin pigmentation in healthy children analysed by nailfold video capillaroscopy
por: Bergkamp, Sandy C., et al.
Publicado: (2023)

Dysregulated endothelial cell markers in systemic lupus erythematosus: a systematic review and meta-analysis
por: Bergkamp, S. C., et al.
Publicado: (2023)

Double inversion recovery MRI versus contrast-enhanced MRI for evaluation of knee synovitis in juvenile idiopathic arthritis
por: Verkuil, Floris, et al.
Publicado: (2022)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

Contrast-enhanced MRI features in the early diagnosis of Juvenile Idiopathic Arthritis
por: Hemke, Robert, et al.
Publicado: (2015)

Immunogenicity of TNF-Inhibitors
por: Atiqi, Sadaf, et al.
Publicado: (2020)

Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls
por: Schonenberg-Meinema, Dieneke, et al.
Publicado: (2021)

Juvenile idiopathic arthritis: magnetic resonance imaging of the clinically unaffected knee
por: van Gulik, E. Charlotte, et al.
Publicado: (2018)

Contrast-enhanced MRI of the knee in children unaffected by clinical arthritis compared to clinically active juvenile idiopathic arthritis patients
por: Nusman, Charlotte M., et al.
Publicado: (2015)

Therapeutic TNF Inhibitors can Differentially Stabilize Trimeric TNF by Inhibiting Monomer Exchange
por: van Schie, Karin A., et al.
Publicado: (2016)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Nailfold capillary scleroderma pattern may be associated with disease damage in childhood-onset systemic lupus erythematosus: important lessons from longitudinal follow-up
por: Schonenberg-Meinema, Dieneke, et al.
Publicado: (2022)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

Dynamic contrast-enhanced magnetic resonance imaging of the wrist in children with juvenile idiopathic arthritis
por: Nusman, Charlotte M., et al.
Publicado: (2016)

MRP8/14 and neutrophil elastase for predicting treatment response and occurrence of flare in patients with juvenile idiopathic arthritis
por: Barendregt, Anouk M, et al.
Publicado: (2020)

Exploring contrast-enhanced MRI findings of the clinically non-inflamed symptomatic pediatric wrist
por: Verkuil, Floris, et al.
Publicado: (2020)

Diffusion-weighted imaging for assessment of synovial inflammation in juvenile idiopathic arthritis: a promising imaging biomarker as an alternative to gadolinium-based contrast agents
por: Barendregt, Anouk M., et al.
Publicado: (2017)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

Talus Arthritis Pattern in Juvenile Idiopathic Arthritis (JIA)
por: Alkhreisat, Mohammad, et al.
Publicado: (2019)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Understanding the biology and use of TNF therapy in jia-clinical outcomes
por: Lovell, Daniel, et al.
Publicado: (2014)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
por: Alpigiani, Maria Giannina, et al.
Publicado: (2014)

4.4 Different phenotype of anaemia in systemic juvenile idiopathic arthritis (s-JIA) compared to anaemia in other subtypes of JIA
por: Hinze, CH, et al.
Publicado: (2008)

The successes and challenges of harmonising juvenile idiopathic arthritis (JIA) datasets to create a large-scale JIA data resource
por: Lawson-Tovey, Saskia, et al.
Publicado: (2023)

Comparison of contrast-enhanced MRI features of the (teno)synovium in the wrist of patients with juvenile idiopathic arthritis and pediatric controls
por: van der Krogt, Jeffrey M. A., et al.
Publicado: (2021)

DNase I levels in JIA – influence of anti-TNF (etanercept) therapy
por: Vojinovic, J, et al.
Publicado: (2008)

Understanding the biology and use of anti-TNF agents in JIA – interim results
por: Lovell, Daniel J, et al.
Publicado: (2012)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA)
por: Hinks, A, et al.
Publicado: (2011)

Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA)
por: Hansmann, Sandra, et al.
Publicado: (2015)

PReS-FINAL-2159: Tocilizumab (TCZ) dosing in juvenile idiopathic arthritis (JIA): optimising for different JIA type and body weight patients
por: Lu, P, et al.
Publicado: (2013)

Safety and efficacy of biological therapy with TNF-inhibitors and non TNF-inhibitors in a cohort of young adults affected by juvenile idiopathic arthritis (JIA): data from a single centre experience
por: Lorenzo, Ceri, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_00sf9td01iktu2q2eguf6025k9